Raising funds in Europe when we carry a disruptive technology such as BIOMIMESYS technology which requires substantial financial investment for R&D is not so easy. Fortunately, Europe has understood this well and is helping entrepreneurs in this laborious task.

In 2020, we entered the Invest Horizon coaching program. We were fortunate to be able to challenge our business plan and pitch with coaches, entrepreneurs and investors during the coaching program. We are pleased now to announce that we have succeeded in this coaching program with 2 new labels on Euroquity:

Last but not least, We are really pleased to announce that we are in the ranking of the top 43 deep tech companies coached by Invest Horizon in 2020.


HCS Pharma secures 20 Million EUR capital commitment from the GEM group - HCS Pharma · August 3, 2021 at 2:11 pm

[…] HCS Pharma has been recognized as Deep Tech Pionner by Hello Tomorrow, and has been listed in the “Top43” Deep Tech companies coached by Invest Horizon European program in […]

BIOMIMESYS®, le futur de la recherche de médicament est "Made in France" - HCS Pharma · November 12, 2021 at 3:19 pm

[…] sommes très heureux de vous rappeler que la technologie BIOMIMESYS® est une deeptech française reconnue au niveau européen et dont toute la R&D et la production se déroule sur le territoire nationale. Nous sommes fier […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.